These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9922770)

  • 41. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neoadjuvant and adjuvant radiochemotherapy for rectal carcinoma].
    Seegenschmiedt MH
    MMW Fortschr Med; 2007 Jun; 149(23):33-5. PubMed ID: 18062575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer.
    Choi HJ; Kim NK; Keum KC; Cheon SH; Shin SJ; Baik SH; Choen JH; Rha SY; Roh JK; Jeung HC; Chung HC; Ahn JB
    Radiother Oncol; 2008 Jun; 87(3):361-6. PubMed ID: 18439695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fractionation protocols in radiotherapy].
    Navarrete S; Marín Górriz FJ; Hernández Vitoria A; Bellosta Ferrer R; López Marín P; Castillo Ramírez A
    Rev Esp Oncol; 1984; 31(3):515-27. PubMed ID: 6546179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.
    Fu KK; Cooper JS; Marcial VA; Laramore GE; Pajak TF; Jacobs J; Al-Sarraf M; Forastiere AA; Cox JD
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):425-38. PubMed ID: 8655364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Adverse effects of concomitant chemoradiotherapy and their prevention and treatment].
    Horová H; Soumarová R; Seneklová Z; Růzicková J
    Cas Lek Cesk; 2003; 142 Suppl 1():53-6. PubMed ID: 12924053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Past, current and future protocols for combined modality therapy in childhood medulloblastoma.
    Kaaijk P; Schouten-van Meeteren AY; Slotman BJ; Kaspers GJ
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):79-90. PubMed ID: 12597352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
    Schefter T; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Sause W; Gaffney D;
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):101-5. PubMed ID: 24331655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.
    Al-Sarraf M; Pajak TF; Byhardt RW; Beitler JJ; Salter MM; Cooper JS
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):777-82. PubMed ID: 9128951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biological basis for concomitant chemoradiotherapy in carcinomas].
    Favaudon V; Noël G
    Bull Cancer; 2005 Dec; 92(12):1027-31. PubMed ID: 16396748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical radiosensitization: why it does and does not work.
    Coleman CN; Mitchell JB
    J Clin Oncol; 1999 Jan; 17(1):1-3. PubMed ID: 10458210
    [No Abstract]   [Full Text] [Related]  

  • 52. Combining radiotherapy with systemic therapies.
    Vokes EE
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):167-9. PubMed ID: 18391914
    [No Abstract]   [Full Text] [Related]  

  • 53. Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer.
    Keene KS; Harman EM; Knauf DG; McCarley D; Zlotecki RA
    Am J Clin Oncol; 2005 Jun; 28(3):217-22. PubMed ID: 15923791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
    Burstein HJ; Bellon JR; Galper S; Lu HM; Kuter I; Taghian AG; Wong J; Gelman R; Bunnell CA; Parker LM; Garber JE; Winer EP; Harris JR; Powell SN
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):496-504. PubMed ID: 16243442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toxicity after cervical cancer treatment using radiotherapy and chemotherapy.
    Jones B
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):56-63. PubMed ID: 19046625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.
    Koukourakis MI; Giatromanolaki A; Schiza S; Kakolyris S; Georgoulias V
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):107-14. PubMed ID: 9989521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concurrent chemoradiotherapy in non-small cell lung cancer.
    Rowell NP; O'rourke NP
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002140. PubMed ID: 15495029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IMRT-SIB with concurrent and neo-adjuvant platinum-based chemotherapy for locally advanced head and neck squamous cell cancer: analysis of clinical outcomes in a retrospective series of a single institution.
    Mazzeo E; Antognoni P; Parmiggiani M; D'Ambrosio C; De Marco G; Marra L; Gottardi G; Bertoni F
    Tumori; 2014; 100(6):652-9. PubMed ID: 25688499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effectiveness of neoadjuvant chemoradiotherapy of locally advanced rectal cancer in conjunction with local hyperthermia and metronidazole].
    Barsukov IuA; Tkachev SI; Tsariuk VF; Gordeev SS; Perevoshchikov AG; Malikhov AG; Oltarzhevskaia ND; Aliev VA; Kuz'michev DV; Glebovskaia VV; Osombaev MSh
    Vopr Onkol; 2011; 57(3):373-7. PubMed ID: 21882611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality and Reporting Accuracy of Phase 1 Drug Radiation Clinical Trials.
    Kim H; Dan TD; Palmer JD; Leiby BE; Lawrence YR; Dicker AP
    JAMA Oncol; 2016 Mar; 2(3):390-1. PubMed ID: 26841256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.